Global Snakebite Initiative USA Foundation Inc

aka Global Snakebite Initiative   |   Belmont, CA   |

Learn how to support this organization
GuideStar Charity Check

Global Snakebite Initiative USA Foundation Inc

EIN: 87-1508852


We take collaborative action to reduce snakebite death and disability by designing and supporting community engagement programs, through hands-on and online training of frontline health workers, and to improve the quality, effectiveness, and affordability of treatment options globally.

Ruling year info


Executive Director

James Reid

Main address

PO Box 464

Belmont, CA 94002 USA

Show more contact info



Subject area info

Environmental education

Health care quality

Health care access

Emergency medical services

Public health

Show more subject areas

Population served info

Children and youth


People of South Asian descent

People of Southeast Asian descent

People of African descent

Show more populations served

NTEE code info

Education N.E.C. (B99)

IRS subsection

501(c)(3) Public Charity

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Tax forms

Show Forms 990


Programs and results

What we aim to solve

SOURCE: Self-reported by organization

It could be a child walking to school in a village near Chennai, India. A mother gathering cooking wood, or a herdsman guiding livestock in any part of sub-Saharan Africa. A rice paddy farmer in Vietnam, or an indigenous elder in Ecuador. Men, women and children going about their daily lives in the poorest and most rural parts of the world faced with an unexpected and avoidable accident. In the United States, snakebites are rarely fatal thanks to well-trained doctors, abundant antivenom, accessible transport and most often, insurance-covered treatment. But in 168 tropical and subtropical countries where more than 7,400 bites occur daily (5 million annually) it’s the POLAR OPPOSITE! People in snakebite endemic countries regularly list a bite from a snake among their greatest fears. We take collaborative action to reduce snakebite death and disability, with a goal to cut the statistics in half by 2030, in alignment with the WHO Snakebite Roadmap.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

The East Africa Snakebite Center of Excellence

GSI is supporting Kenyan experts in the development of the East Africa Snakebite Center of Excellence on the existing Watamu Snake Farm property in Kilifi County, Kenya. This current capital campaign project will fund a new interactive community education center and snakebite education theater, a snakebite treatment and health worker training clinic and trainee dormitory, and a rural retrieval ambulance to greatly improve transportation gaps for snakebite patients. Together with our local Kenyan partners, we’ll work to reverse the cycle of deficiencies by filling long-needed gaps with tangible and tested solutions. A model that will open the door to other centers, or elements of this center which can be replicated in other snakebite endemic countries.

Population(s) Served
People of African descent

GSI is supporting our longtime, trusted Tamil Nadu-based partners in an effort to save lives and limbs across twelve states in India. This massive effort, run by the Centre for Herpetology at the Madras Crocodile Bank, combines rural education, prevention murals and films, incidence data collection, snakebite knowledge surveys, and the distribution of successfully tested prevention kits for agricultural workers to save lives across rural India.

This program will be the largest ever community education project in India—promoting awareness, prevention, conservation, first-aid and health-seeking behavior messaging—which we know is the most immediate and effective way to improve lives and communities. We aim to host 2,500 community education programs, 100 capacity building programs, 5,000 knowledge surveys, 500 prevention kits, 100 murals, and educational films in 11 critical languages.

Population(s) Served
People of South Asian descent

Health workers worldwide are pleading for training in the treatment of snakebite to provide their communities with a fighting chance. What’s more, knowing they will be competently treated will finally give snakebite victims the confidence to seek treatment closer to where they live. GSI is bringing together clinical experts with decades of hands-on field experience to assist the World Health Organization in designing the first-ever series of online, multimedia-rich snakebite treatment training certification courses.

The World Health Organization (WHO) has identified improved training of health workers in diagnosing and treating snake bites as a key priority in their strategy to reduce death and disabilities in all affected countries. The WHO, in collaboration with GSI and our team of experienced clinical experts, is developing the first-ever series of online snakebite training modules for OpenWHO, the WHO’s popular web-based knowledge transfer platform.

Population(s) Served
Pacific Islanders
People of African descent
People of South Asian descent
People of Southeast Asian descent
People of Central American descent

Sub-Saharan Africa has been in the midst of a crisis caused by a lack of access to effective snake antivenoms for over 50 years. While availability is one critical gap to fill, current products available in sub-Saharan Africa poorly neutralize the venoms of mambas and cobras. GSI’s African SnakebiteAID (Antivenom Improved Design) Project aims to change that, along with modernizing key steps in the manufacturing process. After all, as a neglected tropical disease, treatments for snakebite have lagged behind modern technologies for decades.

GSI wants to revolutionize the way we design and manufacture antivenoms. We want to share the technology with existing manufacturers to enable them to rapidly improve current products and get products into use for the treatment of snakebites throughout sub-Saharan Africa to benefit as many victims as possible. The same technology may also improve the effectiveness, safety, and reach of antivenoms in other areas of the world facing similar issues.

Population(s) Served
People of African descent

Where we work

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

From GSI’s East Africa Center of Excellence in Kenya, to our India-wide community education programs, to online health worker snakebite training courses, our projects span the globe! Each and every project fulfills key pillars of the WHO Strategy to reduce deaths and disabilities by half, by 2030.

In 2018, after an historic push by snakebite experts, coordinated worldwide by GSI’s partners, the WHO declared that snakebite envenomation is “a disease whose time has come.” The WHO then adopted a resolution listing snakebite as a “Category A” Neglected Tropical Disease (NTD). The next year, the WHO released a strategic roadmap to reduce snakebite death and disability by 50% by the year 2030. The WHO identified four key pillars:
1. Increased collaboration and partnerships;
2. Empower and engage communities;
3. Strengthen health systems; and
4. Ensure safe, effective treatments.

GSI has designed its programs around these four pillars, and is leading the charge to ensure that the WHO meets its stated goal.

Our approach in addressing the problem starts by understanding the deficiencies in the snakebite cycle based on the cases we hear about daily. The problem begins in communities where people are unsure how to co-exist with the wildlife in their area; not knowing what types of snakes they might encounter, where those snakes are, nor when they might be encountered. When a bite occurs, their community isn’t educated on the appropriate first-aid to be administered in the immediate aftermath of a bite occurrence, nor the urgency of getting their loved one to a medical clinic for treatment.

Even when a victim does reach the nearest medical clinic quickly, it is likely low on equipment and supplies and has staff that is untrained in the treatment of snakebite. The snakebite patient arrives—fearful, scared, and near death—and the doctors can’t help. Often they are just as scared as the victim in front of them. For this reason, the local doctor refers the victim elsewhere, and the likelihood of death or disability increases exponentially. Many patients die in transport. Even if they make it to the next hospital, the antivenom available to a doctor trained in snakebite treatment may not be appropriate for treating the kind of snake that bit the victim.

GSI is addressing the global scourge of snakebite from every possible angle. We’re supporting community educators to increase prevention and first-aid care. We’re training doctors to confidently treat patients. We’re getting rural medical centers the equipment and supplies they need to effectively treat snakebite victims. And we’re improving treatment options with better antivenoms and venom extraction programs. The leading experts worldwide say these are the steps to achieving the WHO’s goal, and GSI is leading a global, coordinated charge to make that goal a reality.

GSI experts have worked in snakebite endemic countries for decades. We are advocates, snakebite and multi-specialty physicians, community educators, scientists, herpetologists, conservationists, even filmmakers. We’ve been on the frontlines and have advocated for change in the local, national, and global arenas. We are the force that has gotten snakebite on the WHO’s agenda as a Category A neglected tropical disease, and we were critical in ushering in the roadmap. We are now doing the work to ensure the roadmap meets the goal.

We are “doers” and act with empathy, purpose and passion. We are driven by those we’ve met in countries far and wide who have suffered and desperately want better outcomes. In turn, we support those on the ground who share these values, implementing country-led solutions for their fellow citizens.

We listen to the needs of impacted communities, guided by the experience of frontline experts and informed by research to design and support bespoke, sustainable and needle-moving projects.

We act with a pioneering spirit, motivated by the achievements made in this young global health movement and the desire to fill gaps as identified by those on the frontlines.

We are nimble and always open to explore new areas of need and collaboration to support short and long-term projects.

We have, and will always play a leading role in fostering community and to support the growth of our movement with new voices and aligned stakeholders.


Global Snakebite Initiative USA Foundation Inc
Fiscal year: Jan 01 - Dec 31

Revenue vs. expenses:  breakdown

SOURCE: IRS Form 990 info
Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2022 info

SOURCE: IRS Form 990


Average of 1150.62 over 1 years

Months of cash in 2022 info

SOURCE: IRS Form 990


Average of 46.3 over 1 years

Fringe rate in 2022 info

SOURCE: IRS Form 990


Average of 8% over 1 years

Funding sources info

Source: IRS Form 990

Assets & liabilities info

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990

Global Snakebite Initiative USA Foundation Inc

Revenue & expenses

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

Fiscal year ending: cloud_download Download Data

Global Snakebite Initiative USA Foundation Inc

Balance sheet

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: cloud_download Download Data

Global Snakebite Initiative USA Foundation Inc

Financial trends analysis Glossary & formula definitions

Fiscal Year: Jan 01 - Dec 31

SOURCE: IRS Form 990 info

This snapshot of Global Snakebite Initiative USA Foundation Inc’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Business model indicators

Profitability info 2022
Unrestricted surplus (deficit) before depreciation $417,515
As % of expenses 398.8%
Unrestricted surplus (deficit) after depreciation $417,515
As % of expenses 398.8%
Revenue composition info
Total revenue (unrestricted & restricted) $522,215
Total revenue, % change over prior year 0.0%
Program services revenue 0.0%
Membership dues 0.0%
Investment income 0.0%
Government grants 0.0%
All other grants and contributions 100.0%
Other revenue 0.0%
Expense composition info
Total expenses before depreciation $104,700
Total expenses, % change over prior year 0.0%
Personnel 73.4%
Professional fees 15.3%
Occupancy 0.0%
Interest 0.0%
Pass-through 0.0%
All other expenses 11.3%
Full cost components (estimated) info 2022
Total expenses (after depreciation) $104,700
One month of savings $8,725
Debt principal payment $0
Fixed asset additions $0
Total full costs (estimated) $113,425

Capital structure indicators

Liquidity info 2022
Months of cash 46.3
Months of cash and investments 46.3
Months of estimated liquid unrestricted net assets 47.9
Balance sheet composition info 2022
Cash $403,866
Investments $0
Receivables $0
Gross land, buildings, equipment (LBE) $0
Accumulated depreciation (as a % of LBE) 0.0%
Liabilities (as a % of assets) 0.1%
Unrestricted net assets $417,515
Temporarily restricted net assets N/A
Permanently restricted net assets N/A
Total restricted net assets $0
Total net assets $417,515

Key data checks

Key data checks info 2022
Material data errors No


The people, governance practices, and partners that make the organization tick.

Letter of Determination is not available for this organization
Form 1023/1024 is not available for this organization

Executive Director

James Reid

James is a former award-winning television executive producer and documentary filmmaker whose passion for change-making storytelling often paved the way to become more involved in supporting and elevating a number of issues. After writing, directing and releasing the snakebite documentary “Minutes to Die”, James was fortunate to work with the Lillian Lincoln Foundation to help move snakebite envenoming out of the shadows through advocacy, directing snakebite-specific project funding and further filmmaking to support prevention and community education initiatives. Seeing the tremendous need to implement programs in alignment with the WHO Roadmap, James had trouble walking away, and founded the Global Snakebite Initiative USA Foundation. Next to his work in snakebite, James has had the privilege of spending the past 20 years in community-building projects in Nicaragua, a result of a television documentary he produced there.

Number of employees

Source: IRS Form 990

Global Snakebite Initiative USA Foundation Inc

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Show data for fiscal year
Compensation data
Download up to 5 most recent years of officer and director compensation data for this organization

There are no highest paid employees recorded for this organization.

This organization has no recorded board members.